Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Global Forecast 2024-2030

Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Global Forecast 2024-2030

The Peptide Synthesis Market size was estimated at USD 636.71 million in 2023 and expected to reach USD 683.44 million in 2024, at a CAGR 7.84% to reach USD 1,080.42 million by 2030.

Peptide synthesis is a complex and advanced chemical process that entails the formation of peptides, which are short chains of amino acids linked by peptide bonds. These peptides play several critical roles in various biological systems, including signaling, regulation of cellular processes, and maintaining structural components. The technique involves adding amino acids to a growing polypeptide chain stepwise while protecting specific functional groups and ensuring high fidelity throughout the process. There is a higher demand for peptide therapeutics due to their increased applications, and pharmaceutical research activities and funding are on the rise across various economies. Moreover, the cosmetics industry is experiencing a growing need for bioactive peptides, contributing to increased peptide synthesis adoption. The lack of standardized rules and regulations for peptide design and difficulties in peptide production hinders its usage. However, the introduction of advanced peptide synthesizers and technologies developed for peptide design and the potential utilization of peptides in nutraceuticals and food preservation is expected to boost their synthesis in the future.

Regional Insights

Peptide synthesis is a crucial technique in the field of biochemistry and pharmaceutical research across the Americas. In North America, the United States holds a dominant position in peptide synthesis usage due to its well-established biopharmaceutical industry, extensive research infrastructure, and considerable investment in life sciences. In South America, countries such as Brazil and Mexico are witnessing increased adoption of peptide synthesis technologies due to expanding biotechnology sectors and governmental support towards research initiatives. The Asia-Pacific peptide synthesis market's robust growth can be attributed to increased R&D investments by governments and private entities, surging demand for novel therapeutic solutions, expanding pharmaceutical & biotechnology industries' footprint within the region, and a thriving CRO landscape. The peptide synthesis market in the EMEA region is experiencing significant growth, driven by technological advancements in synthesizers, increased funding for research and development activities, and a growing demand for synthetic peptides in pharmaceuticals, biotechnology, and other industries. The market has witnessed an influx of new players and collaborations among existing participants to develop innovative technologies for peptide synthesis.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Peptide Synthesis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Higher need and applications of peptide therapeutics
Increase in pharmaceutical research activities and funding across economies
Growing demand for bioactive peptides from the cosmetics industry

Market Restraints

Lack of standard peptide design rules and regulations

Market Opportunities

Development of advanced peptide synthesizers and technologies for peptide design
Emerging applications of peptides in nutraceuticals and food preservation

Market Challenges

Difficulty in development of peptides and instability of the peptides

Market Segmentation Analysis

Product: Growing usage of reagents for forming peptide bonds during synthesis
Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Peptide Synthesis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Peptide Synthesis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition

Biosynth AG, a supplier of materials to the life science industry, has acquired Pepceuticals, a UK-based producer of synthetic peptides with GMP facilities and fill-finish capabilities. This acquisition aligns with the company's objective of providing a comprehensive service to its customers and strengthening their position in the peptide synthesis market.

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

GenScript Biotech Corporation has expanded its production capabilities for complex and modified peptides at its cGMP manufacturing facility in Zhenjiang, China. Through this expansion, the company enables access to convenient one-stop service that offers customers a neoantigen and peptide active pharmaceutical ingredients (API), along with expert consulting support for CMC filing documents and global regulatory strategies.

Mesa Labs Acquires Belyntic’s Peptide Purification Business

Mesa Laboratories, Inc. completed the acquisition of Belyntic GmbH's peptide purification business, to improve its business offerings. This strategic acquisition introduces a range of consumables that offer distinct advantages to Mesa's existing peptide synthesis business. The integration of peptide products reinforces Mesa's commitment to the biopharmaceutical market and its dedication to facilitating expedited therapeutic development.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Peptide Synthesis Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Market Segmentation & Coverage

This research report categorizes the Peptide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Equipment
Chromatography Equipment
Lyophilizers
Peptide Synthesizers
Reagents
Amino Acids
Base Resins
Peptide Coupling Reagents
Peptide Labeling Reagents
Services
Technology
Hybrid & Recombinant Technology
Solid-Phase Peptide Synthesis
Solution-Phase Synthesis
End User
Academic & Research Institutes
Contract Development & Manufacturing Organization/Contract Research Organization
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year